Friday, February 13, 2026
Home Authors Posts by Ogkologos

Ogkologos

4140 POSTS 0 COMMENTS

Sacituzumab Govitecan Does Not Demonstrate a Statistically Significant OS Improvement in...

Ogkologos -
0

AI-Based Score as a Selection Tool for Supplemental MRI After Negative...

Ogkologos -
0

Neoadjuvant Camrelizumab Plus Chemotherapy Demonstrate Superior pCR Compared to Chemotherapy Alone...

Ogkologos -
0

EMA Recommends to Extend Therapeutic Indications for Crizotinib in Paediatric Patients

Ogkologos -
0

Significant Intracranial Efficacy and Survival Benefits of Osimertinib in Patients with...

Ogkologos -
0

CAR22 Shows Durable Efficacy After a Single Infusion in Patients with...

Ogkologos -
0

FDA Approves HPV Tests That Allow for Self-Collection in a Health...

Ogkologos -
0

A Favourable Benefit-Risk Profile for Taletrectinib in TKI-Naїve and Crizotinib-Pretreated Patients...

Ogkologos -
0

FDA Approves Pembrolizumab with Chemotherapy for Primary Advanced or Recurrent Endometrial...

Ogkologos -
0

After 5 Years of Follow-Up, the Median PFS Has Yet To...

Ogkologos -
0
1...495051...414Page 50 of 414

MOST POPULAR

Load more

HOT NEWS

Follow us on Instagram @ogkologos

Το πρώτο ολοκληρωμένο portal για τον καρκίνο. Ενημερωθείτε για τον καρκίνο, καθώς και για τις τελευταίες εξελίξεις.
Contact us: info@ogkologos.com

POPULAR POSTS

POPULAR CATEGORY

Copyright © 2023 Ogkologos.com